简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-12-20 10:23 Carestream Secures Crucial Business Partner Agreement in Algeria
2024-12-20 10:09 Kao Corporation: Regarding the Nomination of Director Candidates for Our Company
2024-12-19 16:59 GC Aesthetics® Announces Decade-Long Clinical Evaluation of PERLE™ Breast Implants
2024-12-19 10:23 Novotech Publishes Report on the Global COVID-19 Clinical Trial Landscape, Highlighting Key Trends, Therapeutic Advancements, and Challenges in Drug Development
2024-12-19 10:15 Novotech Releases Report on Global Parkinson’s Disease Clinical Trial Landscape
2024-12-17 16:11 HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial
2024-12-17 10:33 Novotech Named a Fierce CRO Award Winner in the Excellence in Clinical Trial Management and Global Operations Categories
2024-12-17 10:10 Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development
2024-12-16 15:51 Celltrion Receives Positive CHMP Opinion for Three Biosimilars in the European Union
2024-12-16 10:42 Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis
2024-12-16 10:26 BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell
2024-12-14 01:42 Parse Biosciences Launches Evercode Mouse BCR to Support Antibody Engineering and Development for Drug Discovery Applications
2024-12-13 15:44 Octapharma Injects Efficiency Into Its Supply Chain With Kinaxis
2024-12-13 14:41 Tanner Pharma Expands Global Access to Botensilimab and Balstilimab Through Partnership With Agenus
2024-12-13 14:24 CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union
2024-12-13 13:23 Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus
2024-12-13 10:34 Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas
2024-12-13 10:17 PHC Live Cell Metabolic Analyzer (LiCellMo) Receives 2024 Innovation Award from The Analytical Scientist
2024-12-11 13:19 BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets
2024-12-06 17:52 APRIL Group Continues Its International Expansion by Strengthening Its Presence in China

Business Wire Weibo

Press Releases

Latest Releases